VanRx_Mike said:The shortage clause is the answer to the second question and it is a subtraction rather than an addition.
Thank you — that is the clearest version of this I have read, and I have read a lot of them.
From the other side of the consultation, briefly.
Compounded has been just as effective for me. If compounded supply is the concern, the COA from my 503B pharmacy shows 99.1% purity. Verified by Janoshik.
TinaHashiRN said:Compounded semaglutide formulations for compounded supply: some pharmacies add ingredients like B12, L-carnitine, or BPC-157 to their semaglutide…
503A vs 503B compounding pharmacies for compounded supply — this distinction matters enormously:
| Feature | 503A | 503B |
|---|---|---|
| Regulation | State Board of Pharmacy | FDA-registered |
| Prescription | Required (patient-specific) | Can compound without patient Rx |
| Testing | Varies by state | cGMP required |
| Scale | Small batches | Larger production |
| Quality consistency | Variable | Generally higher |
I strongly recommend 503B facilities. The FDA oversight and cGMP requirements mean more consistent product quality.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsSleepFixSam said:They are two different exemptions from the same federal requirements and they buy different things.
Price comparison for compounded supply across sources I've used:
| Source | Monthly Cost | Type | Purity Verified |
|---|---|---|---|
| Brand (Ozempic) | $1044 | FDA-approved | N/A (pharma) |
| 503B Compounding | $174 | cGMP compounded | Yes (in-house) |
| 503A Compounding | $114 | Patient-specific | Varies |
| Research peptide | $59 | Not for human use | Often Janoshik |
I use the 503B option — best balance of quality, cost, and legality. The brand price is insane but insurance can help if you qualify.
Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.